The Economic Times

'GLP-1 made for US': Medanta founder Dr. Naresh Trehan explains risks for Indians using weight-loss drugs

GLP-1 weight loss drugs: Renowned cardiovascular surgeon Dr. Naresh Trehan has issued a stern warning against the unsupervised use of GLP-1 (Glucagon-like peptide-1) drugs, which have flooded the Indian market following recent patent expirations. While originally developed in the U.S. for severe obesity and Type 2 diabetes, the entry of low-cost generic versions has led to widespread misuse via online pharmacies and wellness clinics.